Down 40% From Recent Highs Can Inovio Pharmaceuticals Stock Rebound?
- Wednesday, March 24, 2021, 7:10
- Market
- Add a comment
We believe that Inovio Pharmaceuticals , a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, is a good buying opportunity at the present time. INO stock trades near $10 currently and it is, in fact, down 27% from its pre-Covid high of around $14…
About the Author
admin123 has written 23527 stories on this site.
